Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year growth guidance.

Related Posts

Pfizer's drug for advanced lung cancer shows promising ...

admin Jun 1, 2024  0  9

Jim Cramer says a double developer stock upgrade signal...

admin Aug 21, 2024  0  10

New Covid FLiRT variants spark concerns of a summer spike

admin May 22, 2024  0  5

Comments

Name

Email

Comment

Post Comment